Biotech · Private company
RedHill Biopharma Limited
Track this companyFree. Adds RedHill Biopharma Limited to your Dealase workspace and tells you when its record changes.
Clinical trials130 recruiting or active
Pipeline programs16From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline16
- Active ComparatorPhase 3 · Helicobacter Pylori InfectionClinicalTrials.gov · fetched Nov 12, 2026
- OpaganibPhase 3 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- Part A: Upamostat 200 mgPhase 3 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Part A: Upamostat 400 mgPhase 3 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- Part B: Upamostat 200 or 400 mgPhase 3 · Covid19ClinicalTrials.gov · fetched Nov 12, 2026
- RHB-102Phase 3 · GastroenteritisClinicalTrials.gov · fetched Nov 12, 2026
- RHB-104Phase 3 · Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RHB-104 (fixed-dose combination: 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine)Phase 3 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- RHB-105Phase 3 · DyspepsiaClinicalTrials.gov · fetched Nov 12, 2026
- RHB-105Phase 3 · Helicobacter Pylori InfectionClinicalTrials.gov · fetched Nov 12, 2026
- RHB-204Phase 3 · Pulmonary Mycobacterium Avium Complex InfectionClinicalTrials.gov · fetched Nov 12, 2026
- ABC294640Phase 2 · CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- Hydroxychloroquine Sulfate 200 MGPhase 2 · CholangiocarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- OpaganibPhase 2 · Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- OpaganibPhase 2 · Coronavirus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- sphingosine kinase-2 inhibitor ABC294640Phase 1 · Pancreatic CancerClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials13
- PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19PHASE2 · COMPLETED · started Jan 29, 2024ClinicalTrials.gov NCT05954286 · fetched Nov 12, 2026
- Upamostat, a Serine Protease Inhibitor, or Placebo for Treatment of COVID-19 DiseasePHASE2_PHASE3 · TERMINATED · started Feb 16, 2021ClinicalTrials.gov NCT04723537 · fetched Nov 12, 2026
- RHB-204 for the Treatment of Pulmonary Mycobacterium Avium Complex DiseasePHASE3 · TERMINATED · started Dec 1, 2020ClinicalTrials.gov NCT04616924 · fetched Nov 12, 2026
- Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 PneumoniaPHASE2_PHASE3 · COMPLETED · started Aug 21, 2020ClinicalTrials.gov NCT04467840 · fetched Nov 12, 2026
- A Study of Opaganib in Coronavirus Disease 2019 PneumoniaPHASE2 · COMPLETED · started Jul 2, 2020ClinicalTrials.gov NCT04414618 · fetched Nov 12, 2026
- A Study of ABC294640 Alone and in Combination With HCQ Sulfate in the Treatment of Advanced CholangiocarcinomaPHASE2 · COMPLETED · started Mar 7, 2018ClinicalTrials.gov NCT03377179 · fetched Nov 12, 2026
- ERADICATE Hp2 - Treating Helicobacter Pylori With RHB-105 Compared to Active ComparatorPHASE3 · COMPLETED · started Jun 18, 2017ClinicalTrials.gov NCT03198507 · fetched Nov 12, 2026
- Open Label Efficacy and Safety of Anti-MAP (Mycobacterium Avium Ssp. Paratuberculosis) Therapy in Adult Crohn's DiseasePHASE3 · COMPLETED · started Mar 18, 2017ClinicalTrials.gov NCT03009396 · fetched Nov 12, 2026
- ABC294640 (Opaganib) in Refractory / Relapsed Multiple MyelomaPHASE1_PHASE2 · TERMINATED · started Dec 13, 2016ClinicalTrials.gov NCT02757326 · fetched Nov 12, 2026
- BEKINDA (Ondansetron 24 mg Bimodal Release Tablets) for Vomiting Due to Presumed Acute Gastroenteritis or GastritisPHASE3 · COMPLETED · started Dec 8, 2014ClinicalTrials.gov NCT02246439 · fetched Nov 12, 2026
- ERADICATE Hp - Treating Helicobacter Pylori With RHB-105PHASE3 · COMPLETED · started Nov 1, 2013ClinicalTrials.gov NCT01980095 · fetched Nov 12, 2026
- Efficacy and Safety of Anti-MAP Therapy in Adult Crohn's DiseasePHASE3 · COMPLETED · started Sep 1, 2013ClinicalTrials.gov NCT01951326 · fetched Nov 12, 2026
- ABC294640 in Treating Patients With Advanced Solid TumorsPHASE1 · COMPLETED · started Aug 1, 2011ClinicalTrials.gov NCT01488513 · fetched Nov 12, 2026